- Home
- / MicroPort NeuroTech
MicroPort NeuroTech
Stock Price
$10
2024-10-29
Market Capitalization
$5.6 B
2024-10-29
Revenue
¥790.5 M
FY, 2025
MicroPort NeuroTech Summary
Company Summary
- Overview
- MicroPort NeuroTech Shanghai (微创神通医疗科技（上海）有限公司) is a company engaged in the research and development, manufacturing, and sales of neuro-interventional products. It offers U-track, an intracranial support catheter system for balloon angioplasty; NUMEN, a coil embolization system; and a device for catheter thrombectomy.
- Type
- Public
- Status
- Active
- Founded
- 2012
- HQ
- Shanghai, CN | view all locations
- Cybersecurity rating
Table of Contents
Key People
Xie Zhiyong, Executive Director and President
Wang Lin, Non-Executive Director
Wu Xia, Non-Executive Director
LocationsView all
1 location detected
Shanghai, Shang Hai Shi HQ
China
1661 Zhangdong Road, Zhangjiang High-tech Park, Pudong New District
MicroPort NeuroTech Financials
Summary Financials
- Revenue (FY, 2025)
- ¥790.5M
- Gross profit (FY, 2025)
- ¥678.1M
- Net income (FY, 2025)
- ¥183.8M
- Cash (FY, 2025)
- ¥611.3M
- EBIT (FY, 2025)
- ¥280.6M
- Enterprise value
- $5.0B